[Scleromyxedema: a new therapeutic proposal].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006118:Griseofulvin / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy* / Q000473:pathology; D010840:Phytosterols / Q000627:therapeutic use; D010936:Plant Extracts / Q000627:therapeutic use; D012872:Skin Diseases, Vesiculobullous / Q000188:drug therapy*; D014810:Vitamin E / Q000627:therapeutic use
D004338:Drug Combinations; D010840:Phytosterols; D010936:Plant Extracts; C003884:piascledine; D014810:Vitamin E; D006118:Griseofulvin; D000324:Adrenocorticotropic Hormone
Scleromixedema: una nuova proposta terapeutica.